JAAD International (Jun 2023)

Physician values in alopecia areata treatment decision-making: A qualitative assessmentCapsule Summary

  • Jane J. Han, MD,
  • Priya Manjaly, BA,
  • Karen J. Lee, BS,
  • Bina Kassamali, MD,
  • Kylee J.B. Kus, MD,
  • Lourdes Maria Pérez-Chada, MD, MMSc,
  • Avery Lachance, MD, MPH,
  • Sara J. Li, BS,
  • Maryanne M. Senna, MD,
  • Kathie P. Huang, MD,
  • Arash Mostaghimi, MD, MPA, MPH

Journal volume & issue
Vol. 11
pp. 14 – 23

Abstract

Read online

Background: Alopecia areata (AA) is a disease of hair loss with multiple treatment options. Physicians play an important role in guiding patients during the decision-making process. Objective: Assess physicians’ values and attitudes when helping patients choose an AA treatment. Methods: Semi-structured qualitative interviews were conducted with dermatologists of varying practice type and location. Each interview was coded independently twice using inductive thematic analysis. Interrater reliability and code frequencies were determined. Results: Fourteen participants were interviewed. Interrater reliability was κ = 0.85 to 0.97. Dermatologists wanted patients to consider various treatment factors (ie, efficacy, safety, convenience of use, accessibility) and also assessed patients’ AA clinical severity and personality traits. Participants often encountered various barriers to effective communication with patients, which may be mitigated by shared decision-making. Shared decision-making tools were perceived to potentially improve patient care and communication, although physicians expressed concern about lack of individualization, limitations of time, and the appropriateness of information. Conclusion: AA treatment decision-making is a complex process that often utilizes the expertise of a dermatologist, during which shared decision-making tools may be of value to both patients and physicians.

Keywords